Condition guide · 8 min read

Lichen planus — supplement adjuncts and what to skip

Updated 2026-05-20 · Reviewed by SupplementScore editors · No sponsorships

Lichen planus is a T-cell-mediated inflammatory disorder that affects skin (typically pruritic, violaceous, flat-topped papules), oral mucosa (white reticular striae, erosions), nails, scalp, and genital mucosa. The mainstay treatments are topical and systemic corticosteroids, calcineurin inhibitors, hydroxychloroquine, and methotrexate for severe cases. The supplement layer is small and adjunctive — useful for symptom relief and modest disease modification, not curative.

Oral and genital lichen planus need surveillance. Erosive oral and genital LP carry a small but real risk of squamous cell carcinoma transformation. Annual or more frequent oral medicine, dermatology, or gynaecology review is appropriate. Any non-healing ulcer or new lesion should be biopsied. No supplement substitutes for that surveillance.

Supplements with credible adjunctive evidence

Tier 2 · Common deficiency in LP cohorts

Vitamin D3

1000–2000 IU/day, titrated to 25-OH-D 30–50 ng/mL

Vitamin D deficiency is more common in patients with lichen planus than in matched controls in multiple cross-sectional series, and small interventional studies suggest deficiency correction may modestly improve disease activity. The mechanism is plausible (vitamin D modulates T-cell function), though randomised data is limited. Test 25-OH-D first and supplement to the normal range.

Tier 2 · Oral lichen planus specifically

Curcumin (bioavailable form) — oral LP

500–1000 mg twice daily of a phospholipid or piperine-enhanced formulation, for 6–12 weeks

Several small RCTs in oral lichen planus (Chainani-Wu 2007, Kia 2015) show modest improvement in pain and clinical scores with oral curcumin, comparable to but not exceeding topical corticosteroids. Bioavailable formulations are essential; standard turmeric capsules have negligible absorption. May also be used adjunctively in cutaneous LP for general anti-inflammatory effect.

Tier 2 · Topical symptom relief in oral LP

Aloe vera (topical)

Topical aloe vera gel (high-purity) applied to oral lesions 2–3× daily

Two small placebo-controlled trials (Choonhakarn 2008, Salazar-Sánchez 2010) showed improvement in oral LP lesion appearance and patient-reported pain. Topical only — oral aloe latex (cathartic) is a different product with safety concerns. Use a dental- or oral-medicine-grade product.

Tier 1 · Systemic anti-inflammatory adjunct

Omega-3 (EPA/DHA)

1.5–2 g combined EPA + DHA daily

Omega-3 modulates T-cell function and inflammatory eicosanoids relevant to a range of T-cell-mediated dermatoses. The LP-specific trial base is small, but the broader inflammatory-skin-disease literature is reasonably supportive. Pause 1 week before any procedure or biopsy where significant bleeding is a concern.

Tier 3 · Limited but plausible evidence

Purslane (Portulaca oleracea) — oral LP

As studied in Agha-Hosseini 2010 trial: 235 mg twice daily for 3 months

A single small trial showed improvement in oral LP lesion scores with oral purslane vs placebo. Not widely available as a standardised supplement; consider only if you can verify product identity and standardisation. Not a substitute for dermatologic care.

What to skip

Practical priority list. Dermatology / oral medicine / gynaecology surveillance → topical or systemic prescribed therapy as indicated → trigger identification (medications, dental amalgam in oral LP, hepatitis C in cutaneous LP) → vitamin D repletion if low → bioavailable curcumin for oral LP → topical aloe vera for symptomatic oral lesions → omega-3 → diet and stress management. Biopsy any non-healing or atypical lesion.

Sources

Read more: